Connect with us

Cannabis

Medical Marijuana and Tuberculosis in the Time of COVID-19

Avatar

Published

on

Medical Marijuana and Tuberculosis in the Time of Covid-19

cannabis and TB

With the worldwide phenomenon of Covid-19 lingering in our midst without indications of leaving soon, there are a few medical conditions that are more under stress than others. One of these conditions is Tuberculosis. In this time of the Covid-19 pandemic, all focus is on the essential services and how to deal with the crisis, but the WHO warns that longs-standing health problems like Tuberculosis should not be forgotten.

Modeling work suggests that the Covid-19 epidemic could lead to a 25% reduction in detecting Tuberculosis over the next few months, and that could ultimately lead to an increase of 13% deaths due to TB. That sets TB mortality rates back 5 years. This is why the WHO urges the medical world to not let their guard drop on the prevention and care of TB. Finding and treating people with tuberculosis should still be a priority.

A Recap on Tuberculosis: What is It?

Tuberculosis, also known as TB for short, is caused by the Mycobacterium Tuberculosis bacteria. The disease attacks normally the lungs but could attack other parts of the body too. This is why it is more sensitive to the coronavirus as well. When detected early enough, there is a strong survival rate, but even so, it still remains one of the top 10 causes of death around the world.

For many years, effective treatments for TB has been looked into. Researchers found that a diet high in protein could treat tuberculosis very well. Something like hemp seeds, high in easily digestible protein, is very similar to human globulin, and therefore makes it perfect for treating TB. Marijuana resin was also found to inhibit TB bacteria growth and other pathogens effectively. Studies found that cannabis is highly effective in combatting methicillin-resistant Staphylococcus aureus (MRSA). Studies show that there are 5 main cannabinoids in marijuana able to fight bacteria because of their anti-bacterial properties. They are:

Cannabidiol or CBD

Delta-9-tetrahydrocannabinol or THC

Cannabigerol

Cannabinol

Cannabichromene

Why TB patients are at an Increased risk of Covid-19 disease.

Because Covid-19 is still a relatively new experience, especially with infection to TB patients, it is anticipated that patients with both TB and Covid-19 might have poorer treatment outcomes. Even more so if the TB treatment is interrupted. This is why TB patients should do everything in their power to stay protected against the coronavirus. People ill with Covid-19 and Tuberculosis show similar symptoms. The coinciding symptoms are cough, difficulty breathing, and fever as both the diseases attack the lungs first. Both agents transmit via close contact, but the incubation period from exposure to disease in TB takes longer. It usually goes together with a slow onset.

While anyone infected with TB may fall ill with the disease, and also Covid-19, some are more prone to falling ill. These include:

Malnourished people

Those with diabetes

Those with HIV

Close contact with people who have TB

Involvement of treating TB patients

The use of IV drugs

Compromised immune systems

Those using tobacco

The immune system is key in protecting against diseases. Those who have a compromised immune system, and babies and younger children, whose immune system is not fully developed yet, are also at high risk.

Symptoms of TB to look out for

Because symptoms are so similar to other lung infections, it makes it difficult to identify. There are a variety of symptoms to pay attention to. They are:

Chest pain when breathing or coughing

Chills

Coughing lasting longer than 3 months

Coughing up blood

Fatigue and fever

Loss of appetite

Night sweat

Weakness and weight loss

Different Types of Tuberculosis

There are two main types of TB, namely:

Active TB – this is the active stage of TB where the bacteria are quickly multiplying and invading various organs of the body. This is the contagious and symptomatic stage of the disease. Everyone in contact with a TB patient should then be tested

Latent TB – The bacteria are present in the body but do not cause symptoms. It is not contagious anymore, but it can jump back to phase A if immunosuppressant meds are taken or other illnesses like HIV or Covid-19 are present.

Cannabis in the treatment of Tuberculosis

Treating TB with cannabis goes back for many years. It was first recorded in India in the time of 1893-1894. Later it was recorded in Africa where cannabis was part of the African pharmacopeia to treat various illnesses of the respiratory illnesses. In Mexico, there also reports of people treated with Tuberculosis.

Hemp seed was reported to be extremely effective in treating TB, especially amongst children. Ground hemp seed is steeped in warm milk for at least 30 minutes, before being pressed and filtered. It should be administered every alternative day. Significant results are found, even to the point where complete healing took place without any other medication. It is thought that the high content of polyunsaturated essential fatty acids found in the primary hemp seed protein, edestin, is important in the treatment of TB.

It is shown that the M. tuberculosis bacteria are destroyed faster when high levels of arachidonic acid are present. Arachidonic acid is produced in the body via the metabolism of linoleic acid, which is found in very high levels in hemp seed.

TB AND COVID-19, READ MORE…

CANNABIS AND TUBERCULOSIS

CANNABIS AND TUBERCULOSIS, READ MORE HERE…

OR..

CANNABIS FOR TB

CANNABIS STRAINS FOR TB, TRY THESE FIRST!

Source: http://cannabis.net/blog/medical/medical-marijuana-and-tuberculosis-in-the-time-of-covid19

Cannabis

Cannabis and the 2020 Election

Avatar

Published

on

Next month, five states will be voting on seven ballot measures to legalize cannabis. A variety of proposals, including constitutional amendments, statutory initiatives, and alternative measures, could establish new medical cannabis markets in two states and expand legalization to include adult use legalization in four states. Three of these proposals would enshrine cannabis possession and consumption within state constitutions.

This article will explore the proposals themselves as well as the short-term implications of legalization on existing license holders and the industry.

2020 cannabis ballot measures policy focus

State-by-State Review

Arizona

Arizona voters have another opportunity to legalize cannabis next month, after narrowly defeating adult use legislation four years ago. In recent years, the Copper State’s medical cannabis market has seen significant MSO expansion, and new mandatory testing requirements launch at the beginning of November.

There are roughly 150 medical cannabis licenses in the state currently — all of which would receive priority status in the application process for adult use licensing. Additionally, diversity applicants and applicants in areas currently lacking cannabis retail access would be fast-tracked applicants.

Prop. 207 does include local control and opt-out provisions, and a new 16% tax would direct revenue to a variety of funds, while retail operators would be able to launch delivery services as soon as 2023.

Mississippi

Mississippi could become the 34th state to legalize cannabis for medical use, but two competing measures are creating complications on the ballot. A citizen-driven campaign led to the placement of Initiative 65, while the legislature responded with Alternative Initiative 65A.

Initiative 65 establishes a medical cannabis program similar to the program structure of many other states; with clearly defined qualifying conditions, possession limits, taxes, registration fees, and a regulator — the state health department. The alternative includes no definitions and only allows smokable cannabis products for terminally ill patients, leaving a highly restrictive market requiring enabling legislation.

Previous bills have been proposed, but never brought to a vote — leaving some skeptical that anything at all may come of Initiative 65A.

Montana

Montana’s existing medical cannabis program relies on a system of caregivers who cultivate cannabis and make manufactured products, including edibles and concentrates. Additionally, there is a limited number of licensed dispensaries throughout the state. Legalization would be a major evolution for Montana, which has seen multiple ballot initiatives and legislative interventions in recent years.

Two measures have been placed: one constitutional amendment to set the age of 21 as the minimum buying age and a measure to establish a commercial adult use market. While no early sales provisions are included, Montana companies would be the only businesses able to start sales for the first year after legalization.

New Jersey

New Jersey voters may make history, legalizing the adult use of cannabis and triggering a race among Mid-Atlantic states to implement sales first. While all of New Jersey’s neighbors have existing medical cannabis programs, none have taken steps to expand further. In recent years, numerous regional state legislatures have attempted to legalize, and Public Question 1 may tip the scales for an entire region with over 50 million residents.

The text of the amendment is brief, but it establishes a definition for ‘cannabis’ while permitting possession, use, and industry operations for adults ages 21 and up. The existing Cannabis Regulatory Commission would be tasked with regulating the industry, but the state legislature must first come to an agreement and pass enabling legislation.

Currently, New Jersey’s medical market includes roughly fifteen licenses, including cultivation and manufacturing, as well as a limited number of dispensaries. The next phase for cannabis in NJ is uncharted territory for now: it is unclear if existing licenses will be given the first opportunity to serve the general public.

Given licensing delays and a slow rollout in Illinois, lawsuits and delays could be in New Jersey’s future — with some analysts suggesting a four-year timeline from amendment passage to full implementation. This may be good news for MSOs, including Columbia Care, Verano, and Acreage Holdings, among others.

South Dakota

South Dakota has long been unfriendly to cannabis in all forms and has some of the nation’s strictest marijuana possession penalties. While other non-medical states have at least given a nod to low-THC medical hemp programs, the Mount Rushmore state hadn’t established any kind of hemp or cannabis program at all until the legislature passed industrial hemp legalization this past spring.

Now, the state could make history as the first to legalize cannabis for medical and adult use purposes at the same time. Two proposals are on the ballot: an initiated measure to launch a medical cannabis program, and a constitutional amendment to fully legalize cannabis, with provisions including adult use, a medical program, and expanded hemp legalization.

Medical use is enshrined in both proposals, while the constitutional amendment would prevent the legislature from any type of statutory tampering to limit a retail market. The constitutional amendment would establish a commercial market for both adult use and medical purposes. Medical use would include home cultivation. As there is no cannabis market in the state at this time, no businesses would be able to take advantage of “early sales” provisions, as seen in other states.

Analysis

Previously, medical cannabis programs and commercial licensing schemes predated adult use legalization, and the majority of these proposals came into existence by way of the ballot. In most of the earliest states to fully legalize, this was the case: Colorado, Washington, Alaska, Oregon, California, Massachusetts, and Nevada all had some form of voter-approved medical cannabis legislation first.

Implementation of adult-use legalization has, however, varied across the states. In these proposals, Arizona, Montana, and New Jersey have existing medical cannabis infrastructures, but the implementation of adult use will likely lead to program changes.

Some legalization measures have allowed for existing medical dispensaries to launch sales to adults during a period of late-stage rulemaking. These businesses have operated under modified compliance rules, with track-and-trace requirements and varying tax rates until legalization rules are completed.

After Oregon voters approved legalization in 2014, the state’s medical market rapidly expanded with early sales on the horizon. At one point, there were more medical dispensaries in the state than Starbucks or McDonald’s locations. That number later dropped as businesses converted their licenses over.

For some of the states with legalization on the ballot this year, the transition out of medical will pose challenges: product shortages, long customer lines, new tax rates, uncertainty over product offerings, and testing requirements on top of an already difficult pandemic business environment.

Overall, legalization measures promise to bring a significant impact to consumers and patients in Arizona, Mississippi, Montana, New Jersey, and South Dakota. It’s hard to quantify the short-term improvements to consumers and industry operators, as passage of these initiatives will set off a flurry of legislative and regulatory discussion over the holidays and into the spring. Existing licensees and hopeful applicants should keep an eye for new opportunities: public comment periods, application deadlines, and new sales opportunities on the horizon.

Source: https://cannabiz.media/cannabis-and-the-2020-election/

Continue Reading

Cannabis

Cuomo advisor predicts New York will legalize pot in April

Avatar

Published

on

New York Governor Andrew Cuomo’s advisor on marijuana policy said this week the Empire State could legalize weed in April of next year with a bill that would serve as a model for other states looking to allow recreational pot in the United States.

Axel Bernabe, assistant counselor to Governor Cuomo, was a guest on the Under The Canopy series, recently launched by Canopy Growth, where he discussed cannabis legalization efforts in New York. According to Bernabe, a bill to legalize marijuana will be introduced through the state budget in January again, while he expects legalization to take effect by April. 

As New Jersey appears ready to legalize marijuana this November, Bernabe said the Cuomo administration has been watching its neighbor “closely.”

“We’re watching New Jersey closely. We’ve always been confident that we’d get to this before New Jersey, so if they pass the referendum they still have to have an agreement between the governor and the Senate over there,” he said.

“If New Jersey can beat us to it, they’ll get a gold star but I still think we’re gonna set the model for this,” Bernabe added, referring to the bill’s social equity provisions, among other things. 

During the interview, Bernabe also said that New York has been monitoring how legalization has been unfolding in Vermont, Maine, and Massachusetts, but has also consulted with states on the West Coast, where the legal pot industry is larger and more developed. 

Regarding hemp, Cuomo’s advisor said the state will release its guidelines and regulations for CBD consumer products early next year as well.

“Those products are already out there, so there’s no sense in pretending they’re not,” Bernabe explained. 

For this reason, the governor and his team have been working on guidelines, which will include maximum dose per serving labeling and warnings about potential THC content in various hemp-derived products. New York has copied a lot of Florida’s hemp regulations while crafting its own policies, Bernabe stated, before telling Canopy Growth’s David Culver that the administration is currently putting the finishing touches to the guidelines. 

Although Governor Cuomo promised his state would legalize weed soon, marijuana legalization was left out of the New York state budget for 2020 due to the coronavirus pandemic, which hit the state particularly badly earlier this year.

Cuomo previously proposed working in conjunction with the neighboring states of New Jersey, Connecticut, and Pennsylvania on coordinating a recreational marijuana system for the region. 

Source: https://greencamp.com/cuomo-advisor-predicts-new-york-will-legalize-pot-in-april/

Continue Reading

Cannabis

PURA Concludes Farmersville Meetings – Deal Imminent

Avatar

Published

on

Dallas, TX – October 20, 2020 – OTC PR WIRE — Puration, Inc. (OTC PINK: PURA) today announced that CEO Brian Shibley concluded a key meeting yesterday essential to finalizing the acquisition of 72-acre property in Farmersville, Texas central to the company’s recently announced Farmersville Brands strategy.  “The acquisition is imminent. Look for an announcement very soon,” said Mr. Shibley.

PURA has scheduled the release of a comprehensive update this Friday, October 23, 2020, to provide the latest information on progress with the Farmersville Brand strategy. The Friday update this Friday will include the latest on the company’s planned dividend of PAO Group, Inc. (OTC PINK: PAOG) stock in conjunction with PURA’s sale of its cannabis cultivation business to PAOG.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

Source: https://otcprwire.com/pura-concludes-farmersville-meetings-deal-imminent/

Continue Reading
Energy1 hour ago

Power Plant Boiler Market by Type, Capacity, Technology, Fuel Type, and Region – Global Forecast to 2025

Energy1 hour ago

Rising Phoenix Royalties Announces Second Yoakum County, Permian Basin, Oil and Natural Gas Royalty Acquisition

Energy2 hours ago

Chem-Dry Grows Amid Pandemic with Signed Agreements to Open 64 New Franchises Across the Nation

Energy2 hours ago

Key Trends and Recent Innovations in Powder Bed Fusion, IDTechEx Identifies

Blockchain News2 hours ago

Bitcoin Breaks $12K Resistance and Aims for $14K as BTC Rallies Higher in the Expense of Altcoins

Energy2 hours ago

Pasternack Now Offers a Broad Selection of Field Replaceable Connectors Available for Same-Day Shipment

AR/VR2 hours ago

Star Wars: Tales from the Galaxy’s Edge Gameplay Trailer Drops With November Date for Oculus Quest

Crunchbase3 hours ago

The Briefing: RVShare raises over $100M, Google disputes charges, and more

Blockchain3 hours ago

Mode Adds Bitcoin to Reserves, Joining Microstrategy and Square

Blockchain3 hours ago

Has Bitcoin met its match with this altcoin?

Crunchbase3 hours ago

Syte Sees $30M Series C For Product Discovery

Blockchain News3 hours ago

What could a Democrat Sweep in US Elections mean for Bitcoin?

Blockchain3 hours ago

Yearn Finance Adds GUSD Vaults and Updated Keep3r Network Details

Blockchain3 hours ago

B2BX Exchange Announces B2BX Token Buyback

Blockchain3 hours ago

Coinend: 1, 2, 3 Take off -New Gamified Crypto Prediction Platform!

Coinpedia4 hours ago

GenTech Proudly Secures Deal with TruLife Distribution to Drive Growth in SINFIT Digital Sales

Blockchain4 hours ago

Coinend: 1, 2, 3, Take off – New gamified crypto prediction platform!

Blockchain4 hours ago

PayPal to allow transactions in Bitcoin, Ethereum etc. from 2021

Blockchain News4 hours ago

Ripple CTO Assesses XRP as a Bridge Cryptocurrency Between CBDCs, Stablecoins, and Fiat

Big Data4 hours ago

Top 10 Big Data trends of 2020

Fintech4 hours ago

5 Things to Know Before Investing in Bitcoin

Crunchbase4 hours ago

Intellimize Closes $12M Round Of New Funding

Crunchbase4 hours ago

Fintech Startups Broke Apart Financial Services. Now The Sector Is Rebundling

CNBC4 hours ago

eBay makes a dedicated portal for officially refurbished gear

Fintech4 hours ago

Headout & Nuclei partner to enable customers to book events & experiences directly from their mobile Banking applications

Blockchain5 hours ago

Community Token Sector Blossoms Alongside Surging NFT Market Caps

Energy5 hours ago

Study Reinforces Sustainability of Ring Container Technologies’ SmartCAN™

Business Insider5 hours ago

AutoNation Board Raises Share Repurchase Authorization – Quick Facts

Business Insider5 hours ago

Conversion Labs Appoints Former White House Physician and U.S. Navy Rear Admiral, Dr. Connie Mariano, to Board of Directors

Business Insider5 hours ago

Mehiläinen Yhtiöt Oy supplements the tender offer document dated 8 January 2020 regarding the public cash tender offer for all shares in Pihlajalinna Plc

Business Insider5 hours ago

AutoNation Inc. Q3 adjusted earnings Beat Estimates

Business Insider5 hours ago

Outlook on the Commercial Aviation Aircraft Tires Global Market to 2025 – by Type, Aircraft Type, Position, End-user & Geography

Business Insider5 hours ago

Global CRO Services Market to Rise Impressively at 9.9% CAGR and Reach US$ 90,926.3 by 2026; forecast to Gain Impetus from Recent Mergers and Acquisitions, says Fortune Business Insights

Business Insider5 hours ago

Broadridge 2020 Sustainability Report Underlines Commitment to ESG

Business Insider5 hours ago

Winnebago Industries Q4 Profit Rises; Revenues Up 39.1% – Quick Facts

Business Insider5 hours ago

TG Therapeutics Announces Fast Track Designation Granted by the FDA to Ublituximab in Combination with Umbralisib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia

Business Insider5 hours ago

Collection Sites Announces Agreement with Sandor Development to Launch Testing Sites at 65 Big Boxstore Locations Across the U.S.

Energy5 hours ago

NextEra Energy Partners, LP third-quarter 2020 financial results available on partnership’s website

Energy5 hours ago

NextEra Energy third-quarter 2020 financial results available on company’s website

Energy5 hours ago

Advisory – Changes to Boralex Management Team

Trending